Home
>
National Drug Code (NDC)
>
Reclipsen
Reclipsen - 52544-954-28 - (Desogestrel and Ethinyl Estradiol)
Drug Information of Reclipsen
| Product NDC: | 52544-954 |
| Proprietary Name: | Reclipsen |
| Non Proprietary Name: | Desogestrel and Ethinyl Estradiol |
| Active Ingredient(s): | & nbsp; Desogestrel and Ethinyl Estradiol |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Reclipsen
| Product NDC: | 52544-954 |
| Labeler Name: | Watson Pharma, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076915 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20050801 |
Package Information of Reclipsen
| Package NDC: | 52544-954-28 |
| Package Description: | 6 BLISTER PACK in 1 CARTON (52544-954-28) > 1 KIT in 1 BLISTER PACK |
NDC Information of Reclipsen
| NDC Code | 52544-954-28 |
| Proprietary Name | Reclipsen |
| Package Description | 6 BLISTER PACK in 1 CARTON (52544-954-28) > 1 KIT in 1 BLISTER PACK |
| Product NDC | 52544-954 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desogestrel and Ethinyl Estradiol |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20050801 |
| Marketing Category Name | ANDA |
| Labeler Name | Watson Pharma, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
